e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Various backgrounds in diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The abilities of MSCT in diagnostic of rheumatoid arthritis
E. M. Minina, V. I. Amosov, O. V. Lukina, A. A. Speranskaya, B. S. Kiaei (St.-Petersburg, Russian Federation)
Source:
Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Session:
Various backgrounds in diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
753
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. M. Minina, V. I. Amosov, O. V. Lukina, A. A. Speranskaya, B. S. Kiaei (St.-Petersburg, Russian Federation). The abilities of MSCT in diagnostic of rheumatoid arthritis. Eur Respir J 2009; 34: Suppl. 53, 753
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The Warrick score for the evaluation of chest CT scan manifestations of rheumatoid arthritis
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Pulmonary manifestations in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 100s
Year: 2006
Pulmonary involvement in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 381s
Year: 2006
Pulmonary involvement in rheumatoid arthritis
Source: Eur Respir Monogr 2019; 86: 44-67
Year: 2019
Pulmonary involvement in rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
Pulmonary abnormalities in newly diagnosed rheumatoid arthritis
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Cavitary nodules in rheumatoid arthritis patients and their prognosis
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018
Pulmonary nodular lesions in rheumatoid arthritis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002
RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients
Source: Eur Respir J 2014; 44: 1082-1085
Year: 2014
Clinical, spirometric and radiological characteristics of Brazilian rheumatoid arthritis patients
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012
Pulmonary disease associated with rheumatoid arthritis
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Latent tuberculosis in patients with rheumatoid arthritis. Evaluating cellular response and new diagnostic strategies
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
The prognostic factors of cases with pulmonary involvement of rheumatoid arthritis at first discharge
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Mortality and clinical features in rheumatoid arthritis and interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Structural pulmonary abnormalities on HRCT are early features of ACPA- positive rheumatoid arthritis
Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked
Year: 2013
The lung in rheumatoid arthritis: drugs versus underlying disease
Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective
Year: 2009
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
Source: Eur Respir J 2010; 35: 1322-1328
Year: 2010
Analysis of lung diseases associated with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 307s
Year: 2006
Plethysmographic profile of patients with rheumatoid arthritis (RA): a comparative study between ACPA positive and negative patients
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Evaluation of the sub-maximal aerobic capacity of patients with rheumatoid arthritis (RA): preliminary data
Source: International Congress 2018 – New methods and concepts in exercise testing
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept